V
Vieworks Co Ltd
KOSDAQ:100120
Vieworks Co Ltd
KOSDAQ:100120
Price:
29 400
KRW
-2.65%
Market Cap:
₩263.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vieworks Co Ltd
KOSDAQ:100120
|
KR |
|
Joeone Co Ltd
SSE:601566
|
CN |
Multiples-Based Value
The Multiples-Based Value of one Vieworks Co Ltd stock under the Base Case scenario is 33 492.93 KRW. Compared to the current market price of 29 400 KRW, Vieworks Co Ltd is Undervalued by 12%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
33 492.93
KRW
Undervaluation 12%
V
Multiples Across Competitors
Competitors Multiples
Vieworks Co Ltd Competitors
Vieworks Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
V
|
Vieworks Co Ltd
KOSDAQ:100120
|
263.8B KRW | 1.1 | 12.9 | 9.4 | 13.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.6B USD | 4.1 | 27.8 | 15.9 | 21.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.4B USD | 16.5 | 58.3 | 44.1 | 54.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.3B USD | 5.1 | 39.2 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.5B USD | 3.2 | 24.4 | 13.5 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.1B USD | 5.2 | 35.9 | 21.1 | 28.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.5B EUR | 1.8 | 19.5 | 11 | 15.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.9 | 44.4 | 24.4 | 26.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.6 | 43.1 | 30.6 | 33.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 2 | 25.5 | 10.1 | 17 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.4B USD | 6 | 21.8 | 15.3 | 17 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
